Diagnostic Performance of the Maximal Systolic Acceleration for Detecting a Significant Stenosis in the Aortoiliac and Popliteal Pathway: A Retrospective Cohort Study.
Siem A Willems, Saskia G Dolfing, Rob C van Wissen, Rutger W van der Meer, Jan van Schaik, Joost R van der Vorst, Abbey Schepers, Jaap F Hamming, Jeroen J W M Brouwers
{"title":"Diagnostic Performance of the Maximal Systolic Acceleration for Detecting a Significant Stenosis in the Aortoiliac and Popliteal Pathway: A Retrospective Cohort Study.","authors":"Siem A Willems, Saskia G Dolfing, Rob C van Wissen, Rutger W van der Meer, Jan van Schaik, Joost R van der Vorst, Abbey Schepers, Jaap F Hamming, Jeroen J W M Brouwers","doi":"10.1177/15266028241309267","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Identifying peripheral arterial disease (PAD) remains challenging with currently used bedside tests. The maximal systolic acceleration (ACC<sub>max</sub>) is a promising noninvasive parameter measured by duplex ultrasonography and reflects the arterial perfusion proximal to its measurement point. The principal aim of this study was to analyze the diagnostic accuracy of the ACC<sub>max</sub> for detecting significant stenosis in different arterial segments, which could be useful in clinical decision-making.</p><p><strong>Materials and methods: </strong>A retrospective cohort study was conducted in a tertiary referral hospital. Patients aged 18 years and older who underwent ACC<sub>max</sub> measurement(s) alongside computed tomography angiography (CTA) of the abdominal aorta and lower extremities were qualified for inclusion. A significant stenosis was defined as a lumen reduction of more than 50% on CTA. Diagnostic accuracy of the ACC<sub>max</sub> was investigated for the aortoiliac and popliteal arterial pathways.</p><p><strong>Results: </strong>A total of 196 patients (373 limbs) were included in the study. Diagnostic performance of the ACC<sub>max</sub> (cut-off value of 7.70 m/s<sup>2</sup>) to detect a significant stenosis in the aortoiliac pathway showed a sensitivity of 89%, specificity of 97%, positive likelihood ratio of 29.23 and negative likelihood ratio of 0.12 (area under the curve [AUC] 0.941). For the popliteal pathway (cut-off value of 6.30 m/s<sup>2</sup>), these results were 90%, 95%, 17.14 and 0.12, respectively, with an AUC of 0.958.</p><p><strong>Conclusion: </strong>The ACC<sub>max</sub> showed a promising diagnostic accuracy for detecting a significant stenosis in the aortoiliac and popliteal pathway.</p><p><strong>Clinical impact: </strong>The maximal systolic acceleration (ACC<sub>max</sub>) is a promising non-invasive parameter measured by duplex ultrasonography to diagnose peripheral arterial disease (PAD) and reflects the arterial perfusion proximal to its measurement point. This study focused on its diagnostic accuracy to detect a significant stenosis in the aortoiliac and popliteal pathway, which revealed to be promising with excellent sensitivity and specificity. These findings suggest that ACC<sub>max</sub> measurements could play a key role in developing a new diagnostic approach for PAD.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"15266028241309267"},"PeriodicalIF":1.7000,"publicationDate":"2024-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Endovascular Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/15266028241309267","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Identifying peripheral arterial disease (PAD) remains challenging with currently used bedside tests. The maximal systolic acceleration (ACCmax) is a promising noninvasive parameter measured by duplex ultrasonography and reflects the arterial perfusion proximal to its measurement point. The principal aim of this study was to analyze the diagnostic accuracy of the ACCmax for detecting significant stenosis in different arterial segments, which could be useful in clinical decision-making.
Materials and methods: A retrospective cohort study was conducted in a tertiary referral hospital. Patients aged 18 years and older who underwent ACCmax measurement(s) alongside computed tomography angiography (CTA) of the abdominal aorta and lower extremities were qualified for inclusion. A significant stenosis was defined as a lumen reduction of more than 50% on CTA. Diagnostic accuracy of the ACCmax was investigated for the aortoiliac and popliteal arterial pathways.
Results: A total of 196 patients (373 limbs) were included in the study. Diagnostic performance of the ACCmax (cut-off value of 7.70 m/s2) to detect a significant stenosis in the aortoiliac pathway showed a sensitivity of 89%, specificity of 97%, positive likelihood ratio of 29.23 and negative likelihood ratio of 0.12 (area under the curve [AUC] 0.941). For the popliteal pathway (cut-off value of 6.30 m/s2), these results were 90%, 95%, 17.14 and 0.12, respectively, with an AUC of 0.958.
Conclusion: The ACCmax showed a promising diagnostic accuracy for detecting a significant stenosis in the aortoiliac and popliteal pathway.
Clinical impact: The maximal systolic acceleration (ACCmax) is a promising non-invasive parameter measured by duplex ultrasonography to diagnose peripheral arterial disease (PAD) and reflects the arterial perfusion proximal to its measurement point. This study focused on its diagnostic accuracy to detect a significant stenosis in the aortoiliac and popliteal pathway, which revealed to be promising with excellent sensitivity and specificity. These findings suggest that ACCmax measurements could play a key role in developing a new diagnostic approach for PAD.
期刊介绍：
The Journal of Endovascular Therapy (formerly the Journal of Endovascular Surgery) was established in 1994 as a forum for all physicians, scientists, and allied healthcare professionals who are engaged or interested in peripheral endovascular techniques and technology. An official publication of the International Society of Endovascular Specialists (ISEVS), the Journal of Endovascular Therapy publishes peer-reviewed articles of interest to clinicians and researchers in the field of peripheral endovascular interventions.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
